I asked this question and was answered in the Q&A. He said the expected anti-cancer efficacy is literally 100% based on past human trial data but he is apply a discount by saying 80%. In other words RC220 is only a reformulation to eliminate the crystallisation problem and hence the efficacy of RC110 should translate to RC220.
- Forums
- General
- General Comments / Chat
I asked this question and was answered in the Q&A. He said the...
-
- There are more pages in this discussion • 305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.41 |
Change
0.000(0.00%) |
Mkt cap ! $239.3M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 313 | $1.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.49 | 2072 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 313 | 1.425 |
1 | 491 | 1.420 |
1 | 235 | 1.415 |
1 | 20 | 1.410 |
6 | 14462 | 1.405 |
Price($) | Vol. | No. |
---|---|---|
1.510 | 687 | 1 |
1.550 | 5000 | 1 |
1.570 | 2500 | 1 |
1.650 | 14567 | 3 |
1.690 | 585 | 1 |
Last trade - 07.06am 07/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
Day chart unavailable